Malignant Brenner tumor of the ovary: radiologic and histopathologic correlation demonstrating benign-to-malignant transition
Nozomi Futaki(Hokkaido University Hospital), Kohsuke Kudo(Hokkaido University), Hidemichi Watari(Hokkaido University of Science), Masato Yoshikawa(Hokkaido University), Hiroko Matsumiya(Hokkaido University Hospital), Hiroyuki Kurosu(Hokkaido University), Fumi Kato(Hokkaido University Hospital), Yosuke Konno(Hokkaido University of Science), Kei Ihira(Hokkaido University), Satonori Tsuneta(Hokkaido University), Hiromi Okada(Hokkaido University Hospital), Daisuke Endo(Hokkaido University), Manami Sakurai(Hokkaido University), Takashi Mitamura(Hokkaido University), Keita Sakamoto(Hokkaido University), Takashi Kamiishi(Hokkaido University Hospital), Rina Kimura(Hokkaido University), Noriko Nishioka(Hokkaido University), Takeru Kuwabara(Hokkaido University), Hiroyuki Yamazaki(Hokkaido University)
Cited by 0
Related Papers
Chemotherapy-Induced IL34 Enhances Immunosuppression by Tumor-Associated Macrophages and Mediates Survival of Chemoresistant Lung Cancer Cells
|Cancer Research|2016|178
Long noncoding RNA NEAT1 drives aggressive endometrial cancer progression via miR-361-regulated networks involving STAT3 and tumor microenvironment-related genes
|Journal of Experimental & Clinical Cancer Research|2019|164
MicroRNA-101 targets EZH2, MCL-1 and FOS to suppress proliferation, invasion and stem cell-like phenotype of aggressive endometrial cancer cells
|Oncotarget|2014|155